7Baggers
 champions oncology, inc. (nasdaq:csbr) q1 2026 earnings call transcript  Insider Monkey Thu, 18 Sep 2025 07:00:00 GMT
 champions oncology reports steady revenue and new leadership  TipRanks Tue, 16 Sep 2025 09:53:08 GMT
 Champions Oncology falls after slight revenue miss in first quarter By Investing.com  Investing.com Australia Tue, 16 Sep 2025 07:00:00 GMT
 champions oncology earnings beat by $0.03, revenue fell short of estimates  Investing.com India Tue, 16 Sep 2025 00:12:26 GMT
 Champions Oncology Reports Quarterly Revenue of $14.0 Million  TradingView Mon, 15 Sep 2025 20:55:00 GMT
 CHAMPIONS ONCOLOGY, INC. SEC 10-Q Report  TradingView Mon, 15 Sep 2025 20:53:00 GMT
 champions oncology posts q1 revenue of $14 mln  TradingView Mon, 15 Sep 2025 20:06:47 GMT
 Champions Oncology Reports Steady Revenue and New Leadership  TipRanks Mon, 15 Sep 2025 07:00:00 GMT
 CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million  ACCESS Newswire Mon, 15 Sep 2025 07:00:00 GMT
 champions oncology reports record quarterly revenue of $14.0 million  ACCESS Newswire Mon, 15 Sep 2025 07:00:00 GMT
 published on: 2025-09-05 02:04:33  Newser Fri, 05 Sep 2025 07:04:33 GMT
 published on: 2025-09-04 03:16:13  Newser Thu, 04 Sep 2025 08:16:13 GMT
 published on: 2025-09-03 04:23:41  Newser Wed, 03 Sep 2025 09:23:41 GMT

Champions Oncology, Inc
(NASDAQ:CSBR) 

CSBR stock logo

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient ...

Founded: 1985
Full Time Employees: 143
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends